![Astex Pharmaceuticals, Inc. logo](/news-release/logo/213737/0/213737.jpg?lastModified=12%2F09%2F2016%2023%3A12%3A02&size=2)
Astex Pharmaceuticals, Cancer Research Technology and The Institute of Cancer Research Announce Epigenetic Drug Discovery Collaboration
September 06, 2012 09:32 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., and CAMBRIDGE, UK, Sept. 6, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small...
![Astex Pharmaceuticals, Inc. logo](/news-release/logo/213737/0/213737.jpg?lastModified=12%2F09%2F2016%2023%3A12%3A02&size=2)
Astex Pharmaceuticals to Participate on Epigenetics Panel at Rodman & Renshaw Conference
September 04, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Sept. 4, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
![Astex Pharmaceuticals, Inc. logo](/news-release/logo/213737/0/213737.jpg?lastModified=12%2F09%2F2016%2023%3A12%3A02&size=2)
Astex Pharmaceuticals to Present at September Investor Conferences
August 30, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Aug. 30, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
![Astex Pharmaceuticals, Inc. logo](/news-release/logo/213737/0/213737.jpg?lastModified=12%2F09%2F2016%2023%3A12%3A02&size=2)
Astex President Awarded Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery
August 20, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Aug. 20, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
![Astex Pharmaceuticals, Inc. logo](/news-release/logo/213737/0/213737.jpg?lastModified=12%2F09%2F2016%2023%3A12%3A02&size=2)
Astex Pharmaceuticals Reports 2012 Second Quarter Financial Results
July 30, 2012 16:00 ET
|
Astex Pharmaceuticals, Inc.
Dacogen Royalty Revenue Increased 25% From Prior Year
$5.4 Million Earned on Phase I Trial Initiation of FGFR Kinase Inhibitor
Dacogen Receives Positive Regulatory Recommendation in the EU for...
![Astex Pharmaceuticals, Inc. logo](/news-release/logo/213737/0/213737.jpg?lastModified=12%2F09%2F2016%2023%3A12%3A02&size=2)
Astex Pharmaceuticals to Announce 2012 Second Quarter Financial Results on July 30, 2012
July 24, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., July 24, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
![Astex Pharmaceuticals, Inc. logo](/news-release/logo/213737/0/213737.jpg?lastModified=12%2F09%2F2016%2023%3A12%3A02&size=2)
DACOGEN(R) Receives a Positive Regulatory Recommendation in the European Union for Treatment of Acute Myeloid Leukemia
July 20, 2012 10:34 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., July 20, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
![Astex Pharmaceuticals, Inc. logo](/news-release/logo/213737/0/213737.jpg?lastModified=12%2F09%2F2016%2023%3A12%3A02&size=2)
Astex Board Member Wins 2012 European Mediscience Award
July 10, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., July 10, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
![Astex Pharmaceuticals, Inc. logo](/news-release/logo/213737/0/213737.jpg?lastModified=12%2F09%2F2016%2023%3A12%3A02&size=2)
Astex Pharmaceuticals Announces Initiation of the Phase 2 Expansion of the SGI-110 Clinical Trial in MDS and AML Patients
June 22, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., June 22, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
![Astex Pharmaceuticals, Inc. logo](/news-release/logo/213737/0/213737.jpg?lastModified=12%2F09%2F2016%2023%3A12%3A02&size=2)
Astex Pharmaceuticals Earns $5.4 Million Milestone on Phase I Trial Initiation of a FGFR Kinase Inhibitor
June 13, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., June 13, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...